<DOC>
	<DOCNO>NCT00282178</DOCNO>
	<brief_summary>The purpose study investigate effect 12-week candesartan treatment compare hydrochlorothiazide insulin sensitivity assess hyperinsulinemic euglycemic clamp .</brief_summary>
	<brief_title>Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects Candesartan , Hydrochlorothiazide Placebo</brief_title>
	<detailed_description>To investigate mechanism underlay diabetes-preventing effect candesartan respect possible impact insulin sensitivity , beta cell function adipose tissue function distribution . For purpose comparison perform hydrochlorothiazide placebo treatment . It hypothesize candesartan improve insulin sensitivity compare hydrochlorothiazide possibly also comparison placebo could explain altered fat tissue function distribution alter sympathetic parasympathetic balance autonomic nervous system . Hydrochlorthiazide choose comparator thiazide recommend firs-line therapy hypertension . This drug class detrimental effect glucose tolerance insulin sensitivity .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Male female 1870 year old Diagnosed hypertension abdominal obesity ( waist circumference great equal 102 cm ( M ) 88 cm ( F ) Uncontrolled hypertension Treatment two concomitant antihypertensive medication Diabetes Mellitus Other endocrine disorder Severe liver disease Severely reduce renal function Malignant disease Alcohol drug abuse Severe psychiatric illness History stroke , myocardial infarction , unstable angina pectoris , participation another clinical trial less two month prior screen visit treatment antiobesity drug antiinflammatory drug immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Metabolic</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Abdominal obesity</keyword>
	<keyword>Insulin sensitivity</keyword>
	<keyword>Hyperinsulinemic euglycemic clamp</keyword>
</DOC>